33160981|t|Celecoxib promotes survival and upregulates the expression of neuroprotective marker genes in two different in vitro models of Parkinson's disease.
33160981|a|Parkinson's disease (PD) is the second most common age-related neurodegenerative disorder after Alzheimer's disease. Increasing evidence highlights the role of age-related chronic inflammation, oxidative stress and mitochondrial dysfunction in the pathogenesis of PD. A combination of these factors impairs the crosstalk between mitochondria and lysosomes, resulting in compromised cell homeostasis. Apolipoprotein D (APOD), an ancient and highly conserved anti-inflammatory and antioxidant lipocalin, and the transcription factor EB (TFEB), a master regulator of mitophagy, autophagy and lysosomal biogenesis, play key roles in these processes. Both APOD and TFEB have attracted attention as therapeutic targets for PD. The aim of this study was to investigate if the selective cyclooxygenase-2 inhibitor celecoxib (CXB) exerts a direct neuroprotective effect in 6-hydroxydopamine (6-OHDA) and paraquat (PQ) PD models. We found that CXB rescued SH-SY5Y cells challenged by 6-OHDA- and PQ-induced toxicity. Furthermore, treatment with CXB led to a marked and sustained upregulation of APOD and the two microphthalmia transcription factors TFEB and MITF. In sum, this study highlights the clinically approved drug CXB as a promising neuroprotective therapeutic tool in PD research that has the potential to increase the survival rate of dopaminergic neurons that are still alive at the time of diagnosis.
33160981	0	9	Celecoxib	Chemical	MESH:D000068579
33160981	127	146	Parkinson's disease	Disease	MESH:D010300
33160981	148	167	Parkinson's disease	Disease	MESH:D010300
33160981	169	171	PD	Disease	MESH:D010300
33160981	199	237	age-related neurodegenerative disorder	Disease	MESH:D019636
33160981	244	263	Alzheimer's disease	Disease	MESH:D000544
33160981	328	340	inflammation	Disease	MESH:D007249
33160981	363	388	mitochondrial dysfunction	Disease	MESH:D028361
33160981	412	414	PD	Disease	MESH:D010300
33160981	548	564	Apolipoprotein D	Gene	347
33160981	566	570	APOD	Gene	347
33160981	610	622	inflammatory	Disease	MESH:D007249
33160981	658	681	transcription factor EB	Gene	7942
33160981	683	687	TFEB	Gene	7942
33160981	799	803	APOD	Gene	347
33160981	808	812	TFEB	Gene	7942
33160981	865	867	PD	Disease	MESH:D010300
33160981	927	943	cyclooxygenase-2	Gene	5743
33160981	954	963	celecoxib	Chemical	MESH:D000068579
33160981	965	968	CXB	Chemical	MESH:D000068579
33160981	1012	1029	6-hydroxydopamine	Chemical	MESH:D016627
33160981	1031	1037	6-OHDA	Chemical	MESH:D016627
33160981	1043	1051	paraquat	Chemical	MESH:D010269
33160981	1053	1055	PQ	Chemical	MESH:D010269
33160981	1057	1059	PD	Disease	MESH:D010300
33160981	1082	1085	CXB	Chemical	MESH:D000068579
33160981	1094	1101	SH-SY5Y	CellLine	CVCL:0019
33160981	1122	1128	6-OHDA	Chemical	MESH:D016627
33160981	1134	1136	PQ	Chemical	MESH:D010269
33160981	1145	1153	toxicity	Disease	MESH:D064420
33160981	1183	1186	CXB	Chemical	MESH:D000068579
33160981	1233	1237	APOD	Gene	347
33160981	1250	1264	microphthalmia	Disease	MESH:D008850
33160981	1287	1291	TFEB	Gene	7942
33160981	1296	1300	MITF	Gene	4286
33160981	1361	1364	CXB	Chemical	MESH:D000068579
33160981	1416	1418	PD	Disease	MESH:D010300
33160981	Negative_Correlation	MESH:D000068579	MESH:D010300
33160981	Association	MESH:D008850	4286
33160981	Positive_Correlation	MESH:D010269	MESH:D064420
33160981	Positive_Correlation	MESH:D000068579	347
33160981	Association	MESH:D010300	347
33160981	Negative_Correlation	MESH:D000068579	MESH:D010269
33160981	Negative_Correlation	MESH:D000068579	5743
33160981	Positive_Correlation	MESH:D000068579	MESH:D008850
33160981	Positive_Correlation	MESH:D016627	MESH:D064420
33160981	Positive_Correlation	MESH:D000068579	4286
33160981	Association	MESH:D008850	7942
33160981	Association	MESH:D007249	347
33160981	Association	MESH:D010300	7942
33160981	Negative_Correlation	MESH:D000068579	MESH:D016627
33160981	Positive_Correlation	MESH:D000068579	7942

